DEF 14A

Company

BRAINSTORM CELL THERAPEUTICS INC.

Filed

November 8, 2023

Period of Report

December 18, 2023

Accession Number

0001104659-23-115829

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →